Adline Chem Lab Ltd
NSE: BSE: 524604
₹14.02
(-4.95%)
Mon, 09 Mar 2026, 06:29 pm
Market Cap0
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KAdline Chem Lab Analysis
dividend
- Unable to evaluate Kamron Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Kamron Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Kamron Laboratories has no debt, it does not need to be covered by operating cash flow.
- Kamron Laboratories has no debt, it does not need to be covered by short term assets.
- Kamron Laboratories has not taken on any debt in the past 5 years.
- Kamron Laboratories has no debt, therefore coverage of interest payments is not a concern.
- Kamron Laboratories has no debt.
management
- The tenure for the Kamron Laboratories board of directors is about average.
- Kamlesh's remuneration is lower than average for companies of similar size in India.
misc
- Kamron Laboratories is not covered by any analysts.
- BSE:524604 has not traded for 39 days.
value
- BSE:524604 is flat (0%) underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:524604 is flat (0%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800